A clear guide to GLP-1 receptor agonists, the class of medications behind Ozempic, Wegovy, and more. Learn what they are, how they work in the body, and how the different options compare for diabetes and weight loss.
GLP-1 Agonists
Novo Nordisk's CEO is calling the US launch of oral Wegovy a record-breaking start. If you've been avoiding weekly injections, this development could change your options. Here's what the pill form of semaglutide actually means for patients.
GLP-1 receptor agonists like semaglutide and tirzepatide have moved weight loss treatment beyond willpower and dieting. This article explains what the scientific and cultural shift means for patients considering or already using these medications, including practical guidance on costs, providers, and what to ask your doctor.
New research suggests GLP-1 medications like semaglutide and tirzepatide don't just suppress appetite. They may actually rewire how the brain assigns value to high-calorie, rewarding foods. Here's what that means for patients considering or currently taking these drugs.
Novo Nordisk has raised its financial guidance after the oral Wegovy pill got off to a faster-than-expected sales start. For patients, this signals a major shift in how GLP-1 treatment could be accessed. Here is what you need to know before asking your doctor about the pill form.
Novo Nordisk's oral semaglutide pill is selling far beyond early expectations, pushing the company's stock up sharply. For patients weighing GLP-1 options, this development raises real questions about access, cost, and whether a pill might work as well as the weekly injection. Here's what you need to know.
Novo Nordisk is pushing forward with an oral version of Wegovy (semaglutide), and early sales momentum is already shifting the company's forecasts. If you're considering GLP-1 therapy or looking for alternatives to weekly injections, here's what this development means for you practically.
GLP-1 medications slow digestion, which can change how your body absorbs other oral drugs. This article explains which medications are most at risk for interactions, what symptoms to watch for, and what to discuss with your prescriber before starting treatment.
An oral form of semaglutide is now available, giving people a needle-free option for managing type 2 diabetes and potentially weight loss. This guide covers who qualifies, how the pill compares to injectable versions, what to expect on cost, and the practical steps to getting a prescription.
